113 related articles for article (PubMed ID: 17376268)
1. [Effects of thymosin-alpha1 on cell immunity function in patients with septic shock].
Chen J
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):153-5. PubMed ID: 17376268
[TBL] [Abstract][Full Text] [Related]
2. [Effect of continuous blood purification and thymosin alpha1 on the cellular immunity in patients with severe sepsis: a prospective, randomized, controlled clinical trial].
Li YN; Zhou LX; Qiang XH; Yu TO; Mao KJ; Feng B; Wen WB; Zou YC; Li WY; Li C
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):139-42. PubMed ID: 19278581
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effects of ulinastatin and thymosin alpha1 on immune-modulation in septic patients].
Su L; Meng FS; Tang YQ; Wen Q; Liu YS; Tang LQ; Duan PK; Luo RJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):147-50. PubMed ID: 19278583
[TBL] [Abstract][Full Text] [Related]
4. [Immune and inflammation confusion in severe sepsis and effects of bi-immunomodulation therapy: a prospective, randomized, controlled clinical trial].
Zhou LX; Tan JJ; Li YN; Luo HT; Shao YH; Qiang XH; Yu TO; Ma MY; Mao KJ; Fang B
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(15):1028-33. PubMed ID: 19595251
[TBL] [Abstract][Full Text] [Related]
5. The Therapeutic Effects of Thymosin α1 Combined with Human Immunoglobulin (Ig) and Bundles on Severe Sepsis: a Retrospective Study.
Li Y; Li CS
Clin Lab; 2015; 61(8):907-16. PubMed ID: 26427133
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study.
Chen H; He MY; Li YM
Chin Med J (Engl); 2009 Apr; 122(8):883-8. PubMed ID: 19493408
[TBL] [Abstract][Full Text] [Related]
7. [The significance of lactic acid in early diagnosis and goal-directed therapy of septic shock patients].
Wang T; Xia Y; Hao D; Sun J; Li Z; Han S; Tian H; Zhang X; Qi Z; Sun T; Gao F; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jan; 26(1):51-5. PubMed ID: 24649525
[TBL] [Abstract][Full Text] [Related]
8. [Prevention Effect of Thymosin-alpha1 Aganist Early Ventilator-associated Pneumonia in Patients with Mechanical Ventilation].
Zhang SS; Li K; Wang YH; Ye BN; Pan Y; Shi XQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):957-9. PubMed ID: 26867337
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of efficacy of thymosin alpha1 in the treatment of sepsis: a systematic review].
Yu Y; Tian JH; Yang KH; Zhang P
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):21-4. PubMed ID: 19141185
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation.
Ji SM; Li LS; Sun QQ; Chen JS; Sha GZ; Liu ZH
Transplant Proc; 2007; 39(1):115-9. PubMed ID: 17275486
[TBL] [Abstract][Full Text] [Related]
11. [Effect of thymosin alpha1 on immunological function and metabolism in peritoneal sepsis rats].
Jiang J; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1377-80. PubMed ID: 15634408
[TBL] [Abstract][Full Text] [Related]
12. Ulinastatin and/or thymosin α1 for severe sepsis: A systematic review and meta-analysis.
Feng Z; Shi Q; Fan Y; Wang Q; Yin W
J Trauma Acute Care Surg; 2016 Feb; 80(2):335-40. PubMed ID: 26517783
[TBL] [Abstract][Full Text] [Related]
13. [Prevention and management of lung infections with thymosin alpha1 in critical patients with tracheotomy].
Huang DP; Yang M; Peng WP; Chen XS; Chen ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):128-9. PubMed ID: 16495194
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
Liu F; Wang HM; Wang T; Zhang YM; Zhu X
BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Acupuncture on Prognosis and Immune Function of Sepsis Patients].
Xiao QS; Ma MY; Zhang XS; Deng MH; Yang Yan Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jul; 35(7):783-6. PubMed ID: 26380438
[TBL] [Abstract][Full Text] [Related]
16. Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.
Jia Z; Feng Z; Tian R; Wang Q; Wang L
Immunopharmacol Immunotoxicol; 2015; 37(4):388-92. PubMed ID: 26250523
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock].
Han XD; Sun H; Huang XY; Zhang SY; Wang YD; Ren K; Li F
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):33-7. PubMed ID: 22248749
[TBL] [Abstract][Full Text] [Related]
19. Analysis of peripheral blood lymphocyte subsets and prognosis in patients with septic shock.
Chen X; Ye J; Ye J
Microbiol Immunol; 2011 Oct; 55(10):736-42. PubMed ID: 21831206
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy and Immunomodulatory Effects of Ulinastatin and Thymosin α1 for Sepsis: A Systematic Review and Meta-Analysis.
Wang FY; Fang B; Qiang XH; Yu TO; Zhong JR; Cao J; Zhou LX
Biomed Res Int; 2016; 2016():9508493. PubMed ID: 27340674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
